J Nutr Biochem 62:143154 Zhang N, Tao J, Gao L, Bi Y, Li P, Wang H, Zhu D, Feng W (2020) Liraglutide attenuates nonalcoholic fatty liver disease by modulating gut microbiota in rats administered a high-fat diet
Counsel patients that GI side effects (nausea, vomiting) during GLP-1 RA titration could impair oral contraceptive absorption through vomiting-related missed doses, and recommend a backup method during the first 4 weeks of titration if vomiting occurs
Given their enhanced stability and bioavailability, these analogues hold promise for therapeutic applications in conditions linked to oxidative stress, including neurodegenerative disorders, chronic inflammation, and metabolic diseases
These ingredients are widely recognized in the dietary supplement category and are commonly found in products designed for active lifestyles and everyday wellness routines
Personalized approaches, including biomarker-guided supplementation and genetic profiling, are proposed to optimize outcomes